detrusitol retard hart forðahylki 2 mg
upjohn eesv - tolterodinum l-tartrat - hart forðahylki - 2 mg
detrusitol retard hart forðahylki 4 mg
upjohn eesv - tolterodinum l-tartrat - hart forðahylki - 4 mg
losartan/hydrochlorothiazide medical valley (licolos plus) filmuhúðuð tafla 100/25 mg
medical valley invest ab - hydrochlorothiazidum inn; losartanum kalíum - filmuhúðuð tafla - 100/25 mg
losartan/hydrochlorothiazide medical valley (licolos plus) filmuhúðuð tafla 50/12,5 mg
medical valley invest ab - losartanum kalíum; hydrochlorothiazidum inn - filmuhúðuð tafla - 50/12,5 mg
eucreas
novartis europharm limited - vildagliptin, kvarta stutt og long-term - sykursýki, tegund 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.
icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - vildagliptin, kvarta stutt og long-term - sykursýki, tegund 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 fyrir tiltæk gögn um mismunandi samsetningar).
zomarist
novartis europharm limited - vildagliptin, kvarta stutt og long-term - sykursýki, tegund 2 - lyf notuð við sykursýki - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.
vildagliptin / metformin hydrochloride accord
accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - sykursýki, tegund 2 - lyf notuð við sykursýki - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 fyrir tiltæk gögn um mismunandi samsetningar).
oxybee
dany bienenwohl gmbh - oxalsýru tvíhýdrat - ectoparasiticides fyrir baugi nota, meðtalin. skordýraeitur - býflugur - fyrir meðferð varroosis (varroa anti -) af býflugur hunang (api mellifera) í ungum-frjáls nýlendur.
dany's bienenwohl
dany bienenwohl gmbh - oxalsýru tvíhýdrat - ectoparasiticides for topical use, incl. insecticides, ectoparaciticides, insecticides and repellents - honey bees - fyrir meðferð varroosis (varroa anti -) af býflugur hunang (api mellifera) í ungum-frjáls nýlendur.